Cargando…
An N-terminal Fragment of the Prion Protein Binds to Amyloid-β Oligomers and Inhibits Their Neurotoxicity in Vivo
A hallmark of Alzheimer disease (AD) is the accumulation of the amyloid-β (Aβ) peptide in the brain. Considerable evidence suggests that soluble Aβ oligomers are responsible for the synaptic dysfunction and cognitive deficit observed in AD. However, the mechanism by which these oligomers exert their...
Autores principales: | Fluharty, Brian R., Biasini, Emiliano, Stravalaci, Matteo, Sclip, Alessandra, Diomede, Luisa, Balducci, Claudia, La Vitola, Pietro, Messa, Massimo, Colombo, Laura, Forloni, Gianluigi, Borsello, Tiziana, Gobbi, Marco, Harris, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597823/ https://www.ncbi.nlm.nih.gov/pubmed/23362282 http://dx.doi.org/10.1074/jbc.M112.423954 |
Ejemplares similares
-
The Anti-Prion Antibody 15B3 Detects Toxic Amyloid-β Oligomers
por: Stravalaci, Matteo, et al.
Publicado: (2016) -
Oligomeropathies, inflammation and prion protein binding
por: Forloni, Gianluigi, et al.
Publicado: (2022) -
Doxycycline for Alzheimer’s Disease: Fighting β-Amyloid Oligomers and Neuroinflammation
por: Balducci, Claudia, et al.
Publicado: (2019) -
Alzheimer’s Disease, Oligomers, and Inflammation
por: Forloni, Gianluigi, et al.
Publicado: (2018) -
Immunopurification of Pathological Prion Protein Aggregates
por: Biasini, Emiliano, et al.
Publicado: (2009)